Authors
Jie Cai, Terry Cheuk-Fung Yip, Jimmy Che-To Lai, Grace Lai-Hung Wong, Andrea On-Yan Luk, Raymond Kwok, Juliana Chung-Ngor Chan, Hye Won Lee, Sally She-Ting Shu, Angel Mei-Ling Chim, Alice Pik-Shan Kong, Jian Sun, Vincent Wai-Sun Wong
Published in
Clinical and molecular hepatology. Oct 27, 2026. Epub Oct 27, 2026.
Abstract
International guidelines recommend routine liver assessment in patients with type 2 diabetes (T2D), but the long-term clinical implications remain unclear. We aimed to characterise the long-term hepatic and extrahepatic outcomes across the vibration-controlled transient elastography (VCTE) spectrum in T2D.
The prospective DM-FibroScan Study consecutively enrolled adults with T2D in Hong Kong during 2013-2014. Baseline controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) were assessed.
1,862 patients were followed for a median of 11.9 years (interquartile range 11.5-12.1). The 10-year cumulative incidence of liver-related events (LREs) was 1.1% (95% CI 0.7-1.7), lower than those of all cause mortality (21.1% [19.2-22.9]), cardiovascular events (12.5% [11.0-14.2]), malignancies (9.7% [8.3-11.1]), and end-stage kidney disease (9.0% [7.7-10.3]). Most participants (84.2%) had baseline LSM <10 kPa and a low LRE incidence (0.4 [0.1-0.8] per 1,000 person-years), with cardiovascular events predominated (14.1 [12.2-16.2] per 1,000 person-years). Patients with LSM >15 kPa (5.3%) exhibited a markedly higher LRE incidence (12.2 [6.1-21.8] per 1,000 person years), approaching the incidences of malignancies and ESKD. LRE incidence per 1,000 person-years was 1.9 in patients with LSM regression (≥10 to <10 kPa) and 28.0 in those with persistently elevated LSM. Patients with elevated baseline LSM also showed higher incidences of extrahepatic outcomes.
LREs were relatively uncommon in the overall T2D population but increased substantially with advanced fibrosis. This study provides natural history data across the VCTE spectrum in a relatively unselected T2D cohort and supports integrating fibrosis assessment into routine T2D care.
PMID:
42935238
Bibliographic data and abstract were imported from PubMed on 27 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 23
- Comments 0